MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2

被引:56
作者
Gao, Feng [1 ]
Wu, Hao [2 ]
Wang, Rui [1 ]
Guo, Yang [1 ]
Zhang, Zefeng [1 ]
Wang, Tao [1 ]
Zhang, Guoliang [1 ]
Liu, Changjiang [1 ]
Liu, Junfeng [1 ]
机构
[1] Hebei Med Univ, Dept Thorac Surg, Hosp 4, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
[2] Hebei Med Univ, Dept Clin Lab, Shijiazhuang, Hebei, Peoples R China
关键词
miR-485-5p; FLOT2; small cell lung cancer; proliferation; metastasis; LIPID RAFT; OSTEOSARCOMA; MICRODOMAINS; GROWTH; METASTASIS; MECHANISM;
D O I
10.1080/21655979.2019.1586056
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
This study is aimed to elucidate the mechanisms underlying the role of miR-485-5p in small cell lung cancer (SCLC). The expression of miR-485-5p were quantified with real time quantitative PCR and it was found that the level of miR-485-5p was lower in SCLC tissues than normal tissues. In cultured SCLC cell lines, overexpression of miR-485-5p reduced cell proliferation, migration, and invasion in vitro, whereas knockdown of miR-485-5p performed contrary. FLOT2 expression was obviously upregulated and negatively correlated with miR-485-5p expression level in SCLC tissues. Overexpression of miR-485-5p significantly inhibited the protein expression of flotillin-2 (FLOT2) in cultured SCLC cells. Luciferase reporter assay confirmed that FLOT2 was a direct target of miR-485-5p in SCLC cells. It is concluded that miR-485-5p, as a tumor suppressor, inhibits the growth and metastasis in SCLC by targeting FLOT2. Upregulation of miR-485-5p expression may be an attractive strategy for SCLC therapy.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 38 条
[31]
Occupational exposure and lung cancer [J].
Spyratos, Dionysios ;
Zarogoulidis, Paul ;
Porpodis, Konstantinos ;
Tsakiridis, Kosmas ;
Machairiotis, Nikolaos ;
Katsikogiannis, Nikolaos ;
Kougioumtzi, Ioanna ;
Dryllis, Georgios ;
Kallianos, Anastasios ;
Rapti, Aggeliki ;
Li, Chen ;
Zarogoulidis, Konstantinos .
JOURNAL OF THORACIC DISEASE, 2013, 5 :S440-S445
[32]
miR-429 Identified by Dynamic Transcriptome Analysis Is a New Candidate Biomarker for Colorectal Cancer Prognosis [J].
Sun, Yingnan ;
Shen, Shourong ;
Tang, Hailin ;
Xiang, Juanjuan ;
Peng, Ya ;
Tang, Anliu ;
Li, Nan ;
Zhou, Weiwei ;
Wang, Zeyou ;
Zhang, Decai ;
Xiang, Bo ;
Ge, Jie ;
Li, Guiyuan ;
Wu, Minghua ;
Li, Xiayu .
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2014, 18 (01) :54-64
[33]
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression [J].
Tang, Hailin ;
Deng, Min ;
Tang, Yunyun ;
Xie, Xinhua ;
Guo, Jiaoli ;
Kong, Yanan ;
Ye, Feng ;
Su, Qi ;
Xie, Xiaoming .
CLINICAL CANCER RESEARCH, 2013, 19 (20) :5602-5612
[34]
Control of translation and mRNA degradation by miRNAs and siRNAs [J].
Valencia-Sanchez, MA ;
Liu, JD ;
Hannon, GJ ;
Parker, R .
GENES & DEVELOPMENT, 2006, 20 (05) :515-524
[35]
RETRACTED: microRNA-802 inhibits epithelial-mesenchymal transition through targeting flotillin-2 in human prostate cancer (Retracted article. See vol. 43, 2023) [J].
Wang, Dawei ;
Lu, Guoliang ;
Shao, Yuan ;
Xu, Da .
BIOSCIENCE REPORTS, 2017, 37
[36]
MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion [J].
Wang, Qiang ;
Cai, Jun ;
Wang, Jingcheng ;
Xiong, Chuanzhi ;
Zhao, Jianning .
TUMOR BIOLOGY, 2014, 35 (12) :12743-12748
[37]
miR-133 involves in lung adenocarcinoma cell metastasis by targeting FLOT2 [J].
Wei, Guangxia ;
Xu, Yahuan ;
Peng, Tao ;
Yan, Jie .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (02) :224-230
[38]
Yu J, 2017, AM J TRANSL RES, V9, P3336